Carroll PR - Search Results

1

Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer.

Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, Suh JH, Zhang L, Cooperberg MR, Carroll PR, Chan JM. Kenfield SA, et al. Among authors: carroll pr. Eur Urol. 2019 Jun;75(6):950-958. doi: 10.1016/j.eururo.2018.12.040. Epub 2019 Jan 10. Eur Urol. 2019. PMID: 30638635 Clinical Trial.

2

Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome.

Small EJ, Carroll PR. Small EJ, et al. Among authors: carroll pr. Urology. 1994 Mar;43(3):408-10. doi: 10.1016/0090-4295(94)90092-2. Urology. 1994. PMID: 7510915

3

Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications.

Shinohara K, Wolf JS Jr, Narayan P, Carroll PR. Shinohara K, et al. Among authors: carroll pr. J Urol. 1994 Jul;152(1):120-3. doi: 10.1016/s0022-5347(17)32832-x. J Urol. 1994. PMID: 7515447

4

Combined role of transrectal ultrasonography, Gleason score, and prostate-specific antigen in predicting organ-confined prostate cancer.

Wolf JS Jr, Shinohara K, Carroll PR, Narayan P. Wolf JS Jr, et al. Among authors: carroll pr. Urology. 1993 Aug;42(2):131-7. doi: 10.1016/0090-4295(93)90635-n. Urology. 1993. PMID: 7690168

5

Negative repeat transurethral resection of prostate fails to identify patients with stage A1 prostatic carcinoma at lower risk of progression: a long-term study.

Ingerman A, Broderick G, Williams RD, Carroll PR. Ingerman A, et al. Among authors: carroll pr. Urology. 1993 Nov;42(5):528-32. doi: 10.1016/0090-4295(93)90263-a. Urology. 1993. PMID: 8236594

6

Cellular proliferative fraction of metastatic lymph nodes predicts survival in stage D1 (TxN+M0) prostate cancer.

Cher ML, Stephenson RA, James BC, Carroll PR. Cher ML, et al. Among authors: carroll pr. J Urol. 1996 May;155(5):1674-7. J Urol. 1996. PMID: 8627851

7

Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.

Presti JC Jr, Hovey R, Carroll PR, Shinohara K. Presti JC Jr, et al. Among authors: carroll pr. J Urol. 1996 Nov;156(5):1685-90. J Urol. 1996. PMID: 8863571 Review.

8

Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.

Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll PR. Parivar F, et al. Among authors: carroll pr. Urology. 1996 Oct;48(4):594-9. doi: 10.1016/S0090-4295(96)00250-6. Urology. 1996. PMID: 8886066 Clinical Trial.

9

The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor.

Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R, Carroll PR. Lubeck DP, et al. Among authors: carroll pr. Urology. 1996 Nov;48(5):773-7. doi: 10.1016/s0090-4295(96)00226-9. Urology. 1996. PMID: 8911524

10

Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy.

Connolly JA, Presti JC Jr, Cher ML, Chew K, Shinohara K, Carroll PR. Connolly JA, et al. Among authors: carroll pr. J Urol. 1997 Aug;158(2):515-8. J Urol. 1997. PMID: 9224336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

828 results

Search Page

Filters